TMEM16A (ANO1) as a therapeutic target in cystic fibrosis
LJV Galietta - Current opinion in pharmacology, 2022 - Elsevier
Cystic fibrosis (CF) is a multi-organ genetic disease caused by loss of function of CFTR, a
cAMP-regulated chloride channel expressed in epithelial cells. In airway epithelia, CFTR …
cAMP-regulated chloride channel expressed in epithelial cells. In airway epithelia, CFTR …
The pharmacology of the TMEM16A channel: therapeutic opportunities
R Al-Hosni, Z Ilkan, E Agostinelli, P Tammaro - Trends in Pharmacological …, 2022 - cell.com
The TMEM16A Ca 2+-gated Cl− channel is involved in a variety of vital physiological
functions and may be targeted pharmacologically for therapeutic benefit in diseases such as …
functions and may be targeted pharmacologically for therapeutic benefit in diseases such as …
Analysis of inhibitors of the anoctamin‐1 chloride channel (transmembrane member 16A, TMEM16A) reveals indirect mechanisms involving alterations in calcium …
M Genovese, M Buccirossi, D Guidone… - British journal of …, 2023 - Wiley Online Library
Background and Purpose Pharmacological inhibitors of TMEM16A (ANO1), a Ca2+‐
activated Cl− channel, are important tools of research and possible therapeutic agents …
activated Cl− channel, are important tools of research and possible therapeutic agents …
[PDF][PDF] Genome‐wide analysis identifies gallstone‐susceptibility loci including genes regulating gastrointestinal motility
Abstract Background and Aims Genome‐wide association studies (GWAS) have identified
several risk loci for gallstone disease. As with most polygenic traits, it is likely that many …
several risk loci for gallstone disease. As with most polygenic traits, it is likely that many …
Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy
S Guo, Y Chen, S Shi, X Wang, H Zhang, Y Zhan… - Pharmacological …, 2020 - Elsevier
TMEM16A plays critical roles in physiological process and may serve as drug targets for
diverse diseases. Recently, TMEM16A has started to be regarded as potential primary lung …
diverse diseases. Recently, TMEM16A has started to be regarded as potential primary lung …
Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas
T Chu, P Yottasan, L de Souza Goncalves, AA Oak… - Translational …, 2024 - Elsevier
Cyclic nucleotide elevation in intestinal epithelial cells is the key pathology causing
intestinal fluid loss in secretory diarrheas such as cholera. Current secretory diarrhea …
intestinal fluid loss in secretory diarrheas such as cholera. Current secretory diarrhea …
Chloride transport modulators as drug candidates
AS Verkman, LJV Galietta - American Journal of Physiology …, 2021 - journals.physiology.org
Chloride transport across cell membranes is broadly involved in epithelial fluid transport, cell
volume and pH regulation, muscle contraction, membrane excitability, and organellar …
volume and pH regulation, muscle contraction, membrane excitability, and organellar …
[HTML][HTML] Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis
Nephrolithiasis is a common and recurrent disease affecting 9% of the US population.
Hyperoxaluria is major risk factor for calcium oxalate kidney stones, which constitute two …
Hyperoxaluria is major risk factor for calcium oxalate kidney stones, which constitute two …
TMEM16A: An alternative approach to restoring airway anion secretion in cystic fibrosis?
H Danahay, M Gosling - International Journal of Molecular Sciences, 2020 - mdpi.com
The concept that increasing airway hydration leads to improvements in mucus clearance
and lung function in cystic fibrosis has been clinically validated with osmotic agents such as …
and lung function in cystic fibrosis has been clinically validated with osmotic agents such as …
[HTML][HTML] SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine
O Cil, PM Haggie, JAT Tan, AA Rivera, AS Verkman - JCI insight, 2021 - ncbi.nlm.nih.gov
SLC26A6 (also known as putative anion transporter 1 [PAT1]) is a Cl–/HCO 3–exchanger
expressed at the luminal membrane of enterocytes where it facilitates intestinal Cl–and fluid …
expressed at the luminal membrane of enterocytes where it facilitates intestinal Cl–and fluid …